Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> AMGEN Latest News

8 HOURS AGO - Yahoo! News

A Must Read - Share

Study raises concerns over Servier, Amgen heart drug

A major clinical study has raised concerns about a drug from private French company Servier that helps lower the heart rate and which was licensed to U.S. Ivabradine is not currently approved in the United States but it is sold in Europe for treating stable angina, or chest pain due to obstruction of heart arteries, and for heart failure, when ...

Tags: Study raises concerns over Servier, Amgen heart drug,  Amgen Latest News

AUG 31, 2014 - Yahoo! News

A Must Read - Share

Early data suggest Sanofi, Regeneron drug may halve heart risk

By Ben Hirschler BARCELONA (Reuters) - An experimental cholesterol-lowering drug from Sanofi and Regeneron Pharmaceuticals roughly halved the number of heart attacks and strokes in a clinical trial, researchers reported on Sunday. The injectable drug, alirocumab, is from a new class of medicines, which are also being developed by Amgen and Pfizer. They lower "bad" LDL cholesterol in a new ...

Tags: Early data suggest Sanofi, Regeneron drug may halve heart risk,  Amgen Latest News

AUG 21, 2014 - Yahoo! News

A Must Read - Share

Lilly psoriasis drug impresses; battle nears with Amgen, Novartis

An experimental new psoriasis treatment from Eli Lilly and Co proved superior to Amgen Inc's blockbuster Enbrel, drawing it closer to a potential marketing battle with new products being developed by Amgen and Novartis AG. Based on favorable results from Phase III trials, Lilly said Thursday it would seek marketing approval in the first half of 2015 for its drug ...

Tags: Lilly psoriasis drug impresses; battle nears with Amgen, Novartis,  Amgen Latest News

AUG 19, 2014 - Yahoo! News

A Must Read - Share

Amgen parathyroid drug succeeds in late-stage trial

(Reuters) - (This story corrects headline and first paragraph in Aug. 18 story to replace "thyroid" with "parathyroid")) Drugmaker Amgen Inc said its experimental drug to reduce parathyroid levels in patients with chronic kidney disease met the main goal in a late-stage trial. The drug, AMG 416, treats hyperparathyroidism, or excessive secretion of parathyroid hormone, in kidney disease patients.

Tags: Amgen parathyroid drug succeeds in late-stage trial,  Amgen Latest News

AUG 19, 2014 - Yahoo! News

A Must Read - Share

Amgen thyroid drug succeeds in late-stage trial

(Reuters) - Drugmaker Amgen Inc said its experimental drug to reduce thyroid levels in patients with chronic kidney disease met the main goal in a late-stage trial. The drug, AMG 416, treats hyperparathyroidism, or excessive secretion of parathyroid hormone, in kidney disease patients. The results follow the recent announcement of positive data from a placebo-controlled late-stage study of AMG 416, ...

Tags: Amgen thyroid drug succeeds in late-stage trial,  Amgen Latest News